UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 379,566 Shares of Doximity, Inc. (NASDAQ:DOCS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 30.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 853,725 shares of the company's stock after selling 379,566 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.46% of Doximity worth $45,580,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of DOCS. Global Retirement Partners LLC boosted its holdings in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after buying an additional 440 shares during the period. UMB Bank n.a. grew its position in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Larson Financial Group LLC raised its stake in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the period. Optimum Investment Advisors purchased a new position in Doximity in the 4th quarter worth approximately $43,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of Doximity during the fourth quarter valued at approximately $50,000. 87.19% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Doximity news, CFO Anna Bryson sold 45,000 shares of the company's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the sale, the chief financial officer now directly owns 357,165 shares in the company, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total value of $113,860.00. Following the transaction, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on DOCS. Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and raised their target price for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Truist Financial lowered their target price on Doximity from $58.00 to $52.00 and set a "hold" rating for the company in a research report on Friday, May 16th. Mizuho reduced their price target on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research report on Friday, May 16th. Needham & Company LLC dropped their price objective on shares of Doximity from $82.00 to $67.00 and set a "buy" rating for the company in a research note on Friday, May 16th. Finally, Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and boosted their target price for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $61.89.

Doximity Price Performance

Shares of NASDAQ:DOCS traded down $0.51 on Wednesday, hitting $51.59. 1,637,916 shares of the company's stock were exchanged, compared to its average volume of 2,094,544. The stock has a market capitalization of $9.63 billion, a price-to-earnings ratio of 51.59, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 12 month low of $25.00 and a 12 month high of $85.21. The business's 50 day simple moving average is $55.91 and its two-hundred day simple moving average is $58.19.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's revenue for the quarter was up 17.1% on a year-over-year basis. During the same quarter last year, the business posted $0.25 earnings per share. Equities analysts forecast that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.